Page last updated: 2024-09-04

docetaxel anhydrous and nitazoxanide

docetaxel anhydrous has been researched along with nitazoxanide in 3 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010)
(docetaxel anhydrous)
Studies
(nitazoxanide)
Trials
(nitazoxanide)
Recent Studies (post-2010) (nitazoxanide)
12,1103,2166,92057385352

Protein Interaction Comparison

ProteinTaxonomydocetaxel anhydrous (IC50)nitazoxanide (IC50)
Aldo-keto reductase family 1 member B1Homo sapiens (human)8.22
Signal transducer and activator of transcription 3Homo sapiens (human)9.89
Anoctamin-1Homo sapiens (human)0.424

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Liu, M; Wang, D; Wu, X; Yin, J; Zhang, D; Zhang, Y; Zhu, G1

Reviews

1 review(s) available for docetaxel anhydrous and nitazoxanide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

2 other study(ies) available for docetaxel anhydrous and nitazoxanide

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Cost-effective In Vivo and In Vitro Mouse Models for Evaluating Anticryptosporidial Drug Efficacy: Assessing Vorinostat, Docetaxel, and Baicalein.
    The Journal of infectious diseases, 2023, 11-11, Volume: 228, Issue:10

    Topics: Animals; Antiprotozoal Agents; Cost-Benefit Analysis; Cryptosporidiosis; Cryptosporidium; Cryptosporidium parvum; Docetaxel; Humans; Mice; Paromomycin; Plant Breeding; Vorinostat

2023
chemdatabank.com